This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, J. A.
Right arrow Articles by Raab-Traub, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrison, J. A.
Right arrow Articles by Raab-Traub, N.

 Previous Article  |  Next Article 

Journal of Virology, November 2003, p. 12276-12284, Vol. 77, No. 22
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.22.12276-12284.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Epstein-Barr Virus Latent Membrane Protein 2A Activates ß-Catenin Signaling in Epithelial Cells

J. A. Morrison,1 A. J. Klingelhutz,2 and N. Raab-Traub1,3*

Department of Microbiology and Immunology,1 Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599,3 Department of Microbiology, University of Iowa, Iowa City, Iowa 522422

Received 23 May 2003/ Accepted 15 August 2003

The Epstein-Barr virus (EBV) latent membrane protein 2A (LMP2A) functions to maintain latency in EBV-infected B lymphocytes. Although LMP2A is nonessential for the immortalization of B lymphocytes by EBV, its expression in B lymphocytes prevents viral reactivation by blocking B-cell receptor activation and signaling. LMP2A also provides an antiapoptotic signal in transgenic mice that express LMP2A in B lymphocytes. LMP2A activates phosphatidylinositol 3-kinase (PI3K) and the serine/threonine kinase Akt in lymphocytes and epithelial cells. Here we show that EBV LMP2A activates the PI3K and ß-catenin signaling pathways in telomerase-immortalized human foreskin keratinocytes (HFK). LMP2A activated Akt in a PI3K-dependent manner, and the downstream Akt targets glycogen synthase kinase 3ß (GSK3ß) and the Forkhead transcription factor FKHR were phosphorylated and inactivated in LMP2A-expressing HFK cells. GSK3ß is a negative regulator of the Wnt signaling pathway, and inactivation of GSK3ß by LMP2A signaling led to stabilization of ß-catenin, the central oncoprotein of Wnt signaling. In LMP2A-expressing cells, ß-catenin accumulated in the cytoplasm and translocated into the nucleus via a two-step mechanism. The cytoplasmic accumulation of ß-catenin downstream of LMP2A was independent of PI3K signaling, whereas its nuclear translocation was dependent on PI3K signaling. In the nucleus, ß-catenin activated a reporter responsive to T-cell factor, and this activation was augmented by LMP2A coexpression. The Wnt pathway is inappropriately activated in 90% of colon cancers and is dysregulated in several other cancers, and these data suggest that activation of this pathway by LMP2A may contribute to the generation of EBV-associated cancers.

* Corresponding author. Mailing address: Lineberger Cancer Center, University of North Carolina-Chapel Hill, Mason Farm Rd., Rm. 102, Chapel Hill, NC 27599. Phone: (919) 966-1701. Fax: (919) 966-9673. E-mail: nrt{at}med.unc.edu.

Journal of Virology, November 2003, p. 12276-12284, Vol. 77, No. 22
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.22.12276-12284.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Tsai, Y.-P., Yang, M.-H., Huang, C.-H., Chang, S.-Y., Chen, P.-M., Liu, C.-J., Teng, S.-C., Wu, K.-J. (2009). Interaction between HSP60 and {beta}-catenin promotes metastasis. Carcinogenesis 30: 1049-1057 [Abstract] [Full Text]  
  • Mansouri, M., Rose, P. P., Moses, A. V., Fruh, K. (2008). Remodeling of Endothelial Adherens Junctions by Kaposi's Sarcoma-Associated Herpesvirus. J. Virol. 82: 9615-9628 [Abstract] [Full Text]  
  • Groen, R. W.J., Oud, M. E.C.M., Schilder-Tol, E. J.M., Overdijk, M. B., ten Berge, D., Nusse, R., Spaargaren, M., Pals, S. T. (2008). Illegitimate WNT Pathway Activation by {beta}-Catenin Mutation or Autocrine Stimulation in T-Cell Malignancies. Cancer Res. 68: 6969-6977 [Abstract] [Full Text]  
  • Shair, K. H.Y., Schnegg, C. I., Raab-Traub, N. (2008). EBV Latent Membrane Protein 1 Effects on Plakoglobin, Cell Growth, and Migration. Cancer Res. 68: 6997-7005 [Abstract] [Full Text]  
  • Anderson, L. J., Longnecker, R. (2008). EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway. J. Gen. Virol. 89: 1563-1568 [Abstract] [Full Text]  
  • Guasparri, I., Bubman, D., Cesarman, E. (2008). EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood 111: 3813-3820 [Abstract] [Full Text]  
  • Fukuda, M., Longnecker, R. (2007). Epstein-Barr Virus Latent Membrane Protein 2A Mediates Transformation through Constitutive Activation of the Ras/PI3-K/Akt Pathway. J. Virol. 81: 9299-9306 [Abstract] [Full Text]  
  • Ding, Q., He, X., Hsu, J.-M., Xia, W., Chen, C.-T., Li, L.-Y., Lee, D.-F., Liu, J.-C., Zhong, Q., Wang, X., Hung, M.-C. (2007). Degradation of Mcl-1 by {beta}-TrCP Mediates Glycogen Synthase Kinase 3-Induced Tumor Suppression and Chemosensitization. Mol. Cell. Biol. 27: 4006-4017 [Abstract] [Full Text]  
  • Shore, A. M., White, P. C., Hui, R. C.-Y., Essafi, A., Lam, E. W.-F., Rowe, M., Brennan, P. (2006). Epstein-Barr Virus Represses the FoxO1 Transcription Factor through Latent Membrane Protein 1 and Latent Membrane Protein 2A. J. Virol. 80: 11191-11199 [Abstract] [Full Text]  
  • Tomita, M., Kikuchi, A., Akiyama, T., Tanaka, Y., Mori, N. (2006). Human T-Cell Leukemia Virus Type 1 Tax Dysregulates {beta}-Catenin Signaling. J. Virol. 80: 10497-10505 [Abstract] [Full Text]  
  • Mainou, B. A., Raab-Traub, N. (2006). LMP1 Strain Variants: Biological and Molecular Properties.. J. Virol. 80: 6458-6468 [Abstract] [Full Text]  
  • Brinkmann, M. M., Schulz, T. F. (2006). Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.. J. Gen. Virol. 87: 1047-1074 [Abstract] [Full Text]  
  • Jang, K. L., Shackelford, J., Seo, S. Y., Pagano, J. S. (2005). Up-regulation of {beta}-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. Proc. Natl. Acad. Sci. USA 102: 18431-18436 [Abstract] [Full Text]  
  • Pegtel, D. M., Subramanian, A., Sheen, T.-S., Tsai, C.-H., Golub, T. R., Thorley-Lawson, D. A. (2005). Epstein-Barr-Virus-Encoded LMP2A Induces Primary Epithelial Cell Migration and Invasion: Possible Role in Nasopharyngeal Carcinoma Metastasis. J. Virol. 79: 15430-15442 [Abstract] [Full Text]  
  • Moody, C. A., Scott, R. S., Amirghahari, N., Nathan, C.-A., Young, L. S., Dawson, C. W., Sixbey, J. W. (2005). Modulation of the Cell Growth Regulator mTOR by Epstein-Barr Virus-Encoded LMP2A. J. Virol. 79: 5499-5506 [Abstract] [Full Text]  
  • Street, A., Macdonald, A., McCormick, C., Harris, M. (2005). Hepatitis C Virus NS5A-Mediated Activation of Phosphoinositide 3-Kinase Results in Stabilization of Cellular {beta}-Catenin and Stimulation of {beta}-Catenin-Responsive Transcription. J. Virol. 79: 5006-5016 [Abstract] [Full Text]  
  • Morrison, J. A., Raab-Traub, N. (2005). Roles of the ITAM and PY Motifs of Epstein-Barr Virus Latent Membrane Protein 2A in the Inhibition of Epithelial Cell Differentiation and Activation of {beta}-Catenin Signaling. J. Virol. 79: 2375-2382 [Abstract] [Full Text]  
  • Allen, M. D., Young, L. S., Dawson, C. W. (2005). The Epstein-Barr Virus-Encoded LMP2A and LMP2B Proteins Promote Epithelial Cell Spreading and Motility. J. Virol. 79: 1789-1802 [Abstract] [Full Text]  
  • Stewart, S., Dawson, C. W., Takada, K., Curnow, J., Moody, C. A., Sixbey, J. W., Young, L. S. (2004). Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-{kappa}B transcription factor pathway. Proc. Natl. Acad. Sci. USA 101: 15730-15735 [Abstract] [Full Text]  
  • Everly, D. N. Jr., Kusano, S., Raab-Traub, N. (2004). Accumulation of Cytoplasmic {beta}-Catenin and Nuclear Glycogen Synthase Kinase 3{beta} in Epstein-Barr Virus-Infected Cells. J. Virol. 78: 11648-11655 [Abstract] [Full Text]  
  • Morrison, J. A., Gulley, M. L., Pathmanathan, R., Raab-Traub, N. (2004). Differential Signaling Pathways Are Activated in the Epstein-Barr Virus-Associated Malignancies Nasopharyngeal Carcinoma and Hodgkin Lymphoma. Cancer Res. 64: 5251-5260 [Abstract] [Full Text]  
  • Shackelford, J., Pagano, J. S. (2004). Tumor Viruses and Cell Signaling Pathways: Deubiquitination versus Ubiquitination. Mol. Cell. Biol. 24: 5089-5093 [Full Text]  
  • Shackelford, J., Maier, C., Pagano, J. S. (2003). Epstein-Barr virus activates {beta}-catenin in type III latently infected B lymphocyte lines: Association with deubiquitinating enzymes. Proc. Natl. Acad. Sci. USA 100: 15572-15576 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»